Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services
Department of Urology

personnel

more pages

training

clinical trials

CLINICAL TRIALS

 
Trial Title Condition Location
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Prostate Cancer Arizona
Cancer
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Renal Cell Carcinoma Arizona
Kidney Cancer
Cancer
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Prostate Cancer Arizona
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Renal Cell Cancer Arizona
SPORE in Prostate Cancer Prostate Cancer Arizona
Cancer
Prostate Cancer
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Cancer Florida
Kidney Cancer
A Study to Evaluate Changes in Phosphate Regulating Factors in Patients with Advanced Renal Cell Carcinoma (RCC) Treated with Sorafenib (Nexavar) Kidney Cancer Florida
Renal Cell Carcinoma
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Prostate Cancer Florida
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Renal Cell Cancer Florida
A Study to Evaluate Changes in Phosphate Regulating Factors in Patients with Advanced Renal Cell Carcinoma (RCC) Treated with Sorafenib (Nexavar) Renal Cell Cancer Florida
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Renal Cell Carcinoma Florida
A Study to Evaluate Changes in Phosphate Regulating Factors in Patients with Advanced Renal Cell Carcinoma (RCC) Treated with Sorafenib (Nexavar) Cancer Florida
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Cancer Florida
Prostate Cancer
Instillation Study - Botox Overactive Bladder Florida
SPORE in Prostate Cancer Cancer Florida
Prostate Cancer
Cancer
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Prostate Cancer Minnesota
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Kidney Cancer Minnesota
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Cancer Minnesota
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Renal Cell Carcinoma Minnesota
Phase 3 Study of Treatment for Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor Renal Cell Cancer Minnesota
A Study to Evaluate Changes in Phosphate Regulating Factors in Patients with Advanced Renal Cell Carcinoma (RCC) Treated with Sorafenib (Nexavar) Cancer Minnesota
Kidney Cancer
Phase 3 Study of Treatment for Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor Renal Cell Carcinoma Minnesota
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer Prostate Cancer Minnesota
E2805, Phase 3 Trial of Sunitinib (Sutent) versus Sorafenib (Nexavar) versus Placebo in Patients with Resected (Surgically Removed) Renal Cell Carcinoma Cancer Minnesota
Renal Cell Cancer
Phase 3 Study of Treatment for Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor Kidney Cancer Minnesota
A Study to Evaluate Changes in Phosphate Regulating Factors in Patients with Advanced Renal Cell Carcinoma (RCC) Treated with Sorafenib (Nexavar) Renal Cell Cancer Minnesota
Renal Cell Carcinoma
Phase 3 Study of Treatment for Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor Cancer Minnesota
SPORE in Prostate Cancer Prostate Cancer Minnesota
Cancer
Prostate Cancer
Cancer
Display in 5 pages


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.